Stay updated on N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial

Sign up to get notified when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:24:14.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy evaluation of N-acetylcysteine (NAC) add-on to antidepressant medication for treating patients with therapy refractory major depressive disorders, focusing on patients who do not respond to standard antidepressant treatment for at least 6 weeks.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:08.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying requirements such as a current episode of Major Depressive Disorder (MDD) diagnosed according to DSM-IV-TR, age range, and specific health conditions. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    28%
    Check dated 2024-05-22T20:56:02.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:39:34.000Z thumbnail image

Stay in the know with updates to N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.